| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $722.2M | — | +43.2% |
| R&D Expense | $10.1M | — | +1.6% |
| SG&A Expense | $74.6M | — | +29.2% |
| Operating Income | -$43.5M | — | +62.1% |
| Pre-tax Income | -$290.3M | — | +25.1% |
| Income Tax | $7.1M | — | +106.4% |
| Net Income | $167.6M | — | +235.2% |
| EPS (Basic) | $0.71 | — | +222.7% |
| EPS (Diluted) | $0.62 | — | +210.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $232.5M | -11.5% | +35.1% |
| Inventory | $490.4M | -2.2% | +18.3% |
| Current Assets | $1.97B | -8.8% | +17.9% |
| Total Assets | $22.77B | +0.7% | +11.7% |
| Current Liabilities | $1.36B | +4.3% | +7.7% |
| Long-term Debt | $14.80B | +0.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $10.6M | — | +110.2% |
| Investing Cash Flow | -$428.6M | — | +34.6% |
| Financing Cash Flow | $270.2M | — | -65.8% |
| +9.1% |
| Total Liabilities | $17.81B | +1.0% | +9.4% |
| Stockholders' Equity | $3.34B | +6.6% | +27.7% |